Metoprolol Alvogen (Metoprolol Tartrate)

Metoprolol Tartrate selectively blocks β1‑adrenergic receptors in the heart, preventing catecholamines from stimulating these receptors. This leads to a slower heart rate, reduced contractile force, and lower cardiac output, which together help to lower arterial pressure and myocardial oxygen demand.

The appropriate dose of Metoprolol Alvogen is individualized by the prescribing clinician based on the patient’s specific condition, response to therapy, age, renal and hepatic function, and any concomitant medications. No fixed regimen is provided here.

The pregnancy safety category for metoprolol tartrate is not definitively established. It should only be used during pregnancy or lactation if the potential benefits outweigh the risks, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Metoprolol is a cardio‑selective beta‑blocker, offering heart‑rate control and reduced myocardial oxygen demand, which differs from ACE inhibitors, calcium‑channel blockers, or diuretics that act on the renin‑angiotensin system, vascular smooth muscle, or fluid balance respectively. Choice depends on patient comorbidities, tolerability and therapeutic goals.

Metoprolol Alvogen tablets should be stored below 25 °C, in the original container, protected from moisture and direct light. Do not store in bathrooms or near heat sources to maintain product stability.

Metoprolol Alvogen is taken orally as a tablet, usually with or without food. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed by a healthcare provider.

Serious adverse events include severe bradycardia, heart block, marked hypotension, bronchospasm in patients with asthma or COPD, and rare allergic reactions such as angioedema. Patients should seek immediate medical attention if they experience fainting, chest pain, severe shortness of breath, or swelling of the face or throat.

Metoprolol Alvogen is contraindicated in patients with known hypersensitivity to metoprolol or other beta‑blockers, those with severe bradycardia, second‑ or third‑degree atrioventricular block without a pacemaker, and individuals with uncompensated heart failure or severe peripheral vascular disease.